International Faculty

Prof. James Allison, PhD

Nobel Laureate 2018,
Regental Professor and Chair, Department of Immunology; Vice President of Immunobiology; Executive Director, Immunotherapy Platform; Director, James P. Allison Institute; Olga Keith Wiess Distinguished University Chair of Cancer Research, MD Anderson Cancer Center (TX, USA)

Prof. Christian Rolfo, MD PhD MBA Drhc

President, International Society of Liquid Biopsy (Spain); Professor of Medicine; Associate Director for Clinical Research Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (NY, USA)

Prof. Don Dizon, MD FACP FASCO

Professor of Medicine and Professor of Surgery; Associate Director, Community Outreach and Engagement, Legorreta Cancer Center; Director of the Pelvic Malignancies Program and Oncology Sexual Health First Responders Clinic, Lifespan Cancer Institute; Director of Medical Oncology, Rhode Island Hospital; Vice Chair for Diversity, Equity, Inclusion (DEI), and Professional Integrity, SWOG, Brown University (RI, USA).

Prof. Faisal Khan, PhD D(ABHI)

CEO, Co-Founder & Director, Molecular Diagnostics, OncoHelix (Canada) in collaboration with coLAB, Burjeel Holdings (UAE); Professor, Cumming School of Medicine; Director, Hematology Translational Lab, University of Calgary (Canada)

Prof. Garth Powis, DPhil

Founder & Consultant, PHusis Therapeutics (CA, USA)

Dr. Hatim Husain, MD

Associate Professor of Medicine, Moores Cancer Center, UC San Diego (CA, USA)

Dr. Helmy Eltoukhy, PhD

Co-Founder and Chairman, Guardant Health (CA, USA)

Dr. Jacob Scott, MD DPhil

Associate Professor, Department of Molecular Medicine; Adjunct Associate Professor, Department of Physics; Associate Director for Data Sciences; Member, Developmental Therapeutics Program, Comprehensive Cancer Center, Case Western Reserve University School of Medicine; Departments of Translational Hematology and Oncology Research and Radiation Oncology Clinic, CWRU School of Medicine and Cleveland Clinic (OH, USA)

Dr. Jason Hipp, MD PhD

Chief Digital Innovation Officer, Mayo Collaborative Services; Medical Director, Biopharma Diagnostics, Mayo Clinic (MN, USA)

Dr. Justin Guinney, PhD

Senior Vice President, Cancer Genomics, Tempus AI (IL, USA)

Dr. Katherine Tossas, PhD MS

Assistant Professor, Department of Health Behavior & Policy; Affiliate Assistant Professor, Epidemiology Division, School of Population Health; Director, Catchment Area Data Access & Alignment (CADA), Office of Community Outreach & Engagement, Massey Cancer Center, Virginia Commonwealth University (VA, USA)

Prof. Padmanee Sharma, MD PhD

Professor, Departments of Genitourinary Medical Oncology and Immunology; Scientific Director, Immunotherapy Platform; T.C. and Jeanette Hsu Endowed Chair in Cell Biology; Co-Director, Parker Institute for Cancer Immunotherapy, MD Anderson Cancer Center (TX, USA)

Dr. Pinaki Bose, PhD

Co-Founder & Executive VP, OncoHelix (Canada) in collaboration with coLAB, Burjeel Holdings (UAE); Scientific Lead, Precision Oncology and Experimental Therapeutics; Director, Tumour Biology and Translational Research, Ohlson Research Initiative, Cumming School of Medicine, University of Calgary (Canada)

Prof. Razelle Kurzrock, MD

Chief Medical Officer / Equal Opportunities and Diversity Officer, WIN Consortium; Professor of Medicine, Associate Director, Clinical Research; Chair of Precision Oncology, MCW Cancer Center and Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine; Founding Director, Michels Rare Cancers Research Laboratories, Froedtert and Medical College of Wisconsin (WI, USA)

Prof. Sendurai Mani, PhD

Associate Director for Translational Oncology, Legorreta Cancer Center; Professor of Pathology and Laboratory Medicine, Dean's Chair of Translational Oncology; Director of Translational Research Disease Groups and Stem Cell Center, Warren Alpert Medical School, Brown University (RI, USA)

Prof. Silvia Formenti, MD

Professor of Medicine and Radiation Oncology; Chair of Radiation Oncology; Sandra and Edward Meyer Professor of Cancer Research; Associate Director of the Meyer Cancer Center; Radiation Oncologist in Chief, NewYork-Presbyterian Hospital, Weill Cornell Medical College (NY, USA)

Dr. Vivek Subbiah, MD

Chief, Early-Phase Drug Development, Sarah Cannon Research Institute (TN, USA)

Prof. Wafik El-Deiry, MD PhD FACP

Chair, WIN Consortium; American Cancer Society Research Professor; Director, Legorreta Cancer Center; Associate Dean, Oncologic Sciences, Warren Alpert Medical School, Brown University (RI, USA)

Dr. Vladimir Lazar, MD PhD

Chief Scientific and Operating Officer, WIN Consortium (France)

Local Faculty

Dr. Alison Finall, MD FRCPath

Consultant Anatomical Pathologist, Burjeel Medical City (UAE)

Dr. Hassan Jaafar, MD

Consultant Medical Oncology, Burjeel Medical City (UAE)

Prof. Humaid Al-Shamsi, MD FACP FRCP(Lon) FRCP(Ca)

Director of Oncology Services, Burjeel Holdings; Professor, Gulf Medical University; President, Emirates Oncology Society (UAE)

Dr. Ibrahim Abu-Gheida, MD

Clinical Director of Radiation Oncology; Chief Medical Officer, Burjeel Medical City (UAE)

Prof. Khaled Musallam, MD PhD

Group Chief Research Officer, Burjeel Holdings; Adj. Professor, Khalifa University (UAE)

Mohamed Mostafa

CEO, Pharmaceutical Development Company, PDC-CRO (UAE)

Dr. Mohamed Salem AlAmeri, PhD

Section Head, Studies and Special Projects, Department of Health – Abu Dhabi (UAE)

Dr. Shahin Fattahi, PhD MCCPM MACPSEM

Administrative Director, Departments of Radiation Oncology and Nuclear Medicine
Burjeel Medical City (UAE)

Scroll to Top